Stock Price & Overview Analyze With AI Follow74.5K followers $40.840.54 (+1.34%)12:29 PM 01/17/25 NASDAQ |$USD |Realtime CRSP Analysis CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers Investing Groups Covering CRSP
Find annual and quearterly earnings data for CRISPR Therapeutics AG Common Shares (CRSP) including earnings per share, earnings forecasts at Nasdaq.com.
CRSPCRISPR Therapeutics AG Charting Follow74.43K followers $39.69-1.60(-3.88%)4:00 PM 01/10/25 NASDAQ |$USD |Post-Market:$39.60-0.09(-0.23%)7:58 PM CRSP stock vs. SP500 chart + Select Symbols+ Select Metrics 1D 5D 1M 6M YTD
CRISPR Therapeutics (NASDAQ:CRSP) Upgraded by StockNews.com to “Sell” Rating Dec 30, 2024Head to Head Survey: CRISPR Therapeutics (NASDAQ:CRSP) vs. Inhibikase Therapeutics (NYSE:IKT) Dec 30, 2024CRISPR Therapeutics (NASDAQ:CRSP) Reaches New 12-Month Low – Here’s Why Learn more by ...
公司概况 公司名称 CRISPR Therapeutics AG 所属市场 NASDAQ 成立日期 2013 员工人数 407 办公地址 Baarerstrasse 14,Zug,Zug,Switzerland 公司网址 http://www.crisprtx.com 邮政编码 6300 联系电话 41 41 561 32 77 联系传真 - - 公司概况 CRISPR Therapeutics AG作为一家瑞士股份公司在Inception Genomics AG名...
ZUG, Switzerland and BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today reported financial results for the first quarter ended March 31, 2024. “This ...
ZUG, Switzerland and BOSTON, April 01, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation at the American Society of Gene & Cell Therapy...
An approval decision carries huge implications for CRSP stock and the broader industry. Source: rafapress / Shutterstock.com Shares of genetic engineering specialistCRISPR Therapeutics(NASDAQ:CRSP) moved up modestly on Friday as stakeholders await a final regulatory decision regarding a key therapeutic....
最近访问:CRISPR Therapeutics AG --- 全球指数美股行情美股吧国际期货 - -- 今开: - 最高价: - 成交量: - 外盘: - 昨收: - 最低价: - 成交额: - 内盘: - 总股本: - 振幅: - 换手率: - 每股收益TTM: - 总市值: - 市净率MRQ: - ...
CRISPR Therapeutics Total Shareholder Return (TSR): -46.4% in 2022 and -12.6% 3-yr returns (below peer average) 2021-09-29 CRISPR Therapeutics AG (CRSP) Stock Expected Return: AI Predicts CRSP Expected Return After a Rise Or Drop